Pharmaceutical Grade Lumefantrine for WHO-Compliant Therapies

 At Prism Industries Pvt. Ltd., we’re proud to be at the forefront of producing high-quality lumefantrine—a crucial antimalarial active pharmaceutical ingredient (API) that supports WHO-compliant therapies. Our dedication to quality and innovation empowers us to assist global pharmaceutical companies in their search for dependable API solutions. The lumefantrine IP USP we create adheres to international pharmacopoeial standards and meets the strictest regulatory requirements.

As one of India’s top API manufacturers, we prioritize quality assurance, environmental responsibility, and customer satisfaction. Our extensive facilities and expertise in bulk drug production make us a reliable partner for governments, NGOs, and pharmaceutical companies striving to fight malaria around the world.

Understanding Lumefantrine: A Potent Antimalarial Agent

Lumefantrine IP USP is often used in fixed-dose combinations with artemether to treat uncomplicated Plasmodium falciparum malaria. It effectively disrupts the parasite's ability to detoxify heme, helping to clear the malarial parasite from the bloodstream.

Recognized on the WHO’s list of essential medicines, lumefantrine is a vital part of artemisinin-based combination therapies (ACTs), highlighting its importance in saving lives in malaria-prone areas. As a trusted bulk drug manufacturer, Prism ensures that every batch of lumefantrine is produced in facilities certified by WHO-GMP.

Discover the Key Features of Our Pharmaceutical Grade Lumefantrine

- Exceptional purity levels that meet IP/USP standards

- Rigorous quality control at every stage of production

- Reliable and consistent performance in various formulations

- Extended shelf life with optimal storage conditions

- Packaging and labeling that comply with all regulations

Thanks to our meticulous manufacturing process, our clients can trust that our lumefantrine delivers safety, effectiveness, and therapeutic benefits.

Lumefantrine Manufacturing: Our Pledge to Quality

As a leading API manufacturer in India, Prism Industries utilizes cutting-edge production technologies, skilled chemists, and real-time monitoring systems to guarantee batch consistency and purity. Our facilities adhere to:

- WHO-GMP standards

- EU-GMP regulations

- ISO certifications

- Local and international compliance requirements

We also offer comprehensive documentation, including DMF, COA, and stability data, to help you navigate global market access with ease.

When it comes to supplying API Bulk Drugs for global markets, we take pride in being a top-tier supplier that can handle large orders without compromising on quality. At Prism Industries, we cater to both public and private sectors, providing:

- Tailored packaging solutions

- Flexible batch sizes

- Secure logistics across the globe

- Quick lead times and reliable delivery

We specialize in exporting lumefantrine IP USP to regions like Africa, Southeast Asia, and Latin America, where controlling malaria is a critical concern.

So, why should you choose Prism Industries Pvt. Ltd. for your lumefantrine needs?

- We have a solid track record in manufacturing antimalarial APIs.

- Our facilities are equipped with cutting-edge technology and validated processes.

- We operate with transparency and uphold ethical business practices.

- Our team offers expert regulatory support to help with product registration.

- We are committed to sustainability and green manufacturing practices.

As a dependable bulk drugs manufacturer, we ensure that our partners around the world enjoy a stable supply chain for the long haul.

When it comes to supplying API Bulk Drugs for global markets, we take pride in being a top-tier supplier that can handle large orders without compromising on quality. At Prism Industries, we cater to both public and private sectors, providing:

- Tailored packaging solutions

- Flexible batch sizes

- Secure logistics across the globe

- Quick lead times and reliable delivery

We specialize in exporting lumefantrine IP USP to regions like Africa, Southeast Asia, and Latin America, where controlling malaria is a critical concern.

So, why should you choose Prism Industries Pvt. Ltd. for your lumefantrine needs?

- We have a solid track record in manufacturing antimalarial APIs.

- Our facilities are equipped with cutting-edge technology and validated processes.

- We operate with transparency and uphold ethical business practices.

- Our team offers expert regulatory support to help with product registration.

- We are committed to sustainability and green manufacturing practices.

As a dependable bulk drugs manufacturer, we ensure that our partners around the world enjoy a stable supply chain for the long haul.

Lumefantrine and WHO Guidelines: Ensuring Therapeutic Compliance

The World Health Organization (WHO) has put artemether-lumefantrine at the forefront as the go-to treatment for uncomplicated malaria. Sticking to WHO-prequalified standards is crucial for ensuring patient safety and the effectiveness of the treatment. Our lumefantrine IP USP is crafted under these strict guidelines, making it perfect for:


- Government tenders

- Non-profit procurement programs

- Global malaria control initiatives


We take great pride in providing WHO-compliant APIs that bolster global health efforts.

Environmental and Social Responsibility in API Manufacturing

We’re dedicated to responsible manufacturing, which includes:


- Zero liquid discharge (ZLD) plants

- Low-emission processes

- Waste minimization and recycling initiatives

- Ethical sourcing of raw materials


As a leading API manufacturer in India, we align our practices with sustainable development goals (SDGs), promoting both human and environmental well-being.


At Lumefantrine Production, we’re all about pushing the boundaries of research and innovation. Our ongoing investments focus on:


Boosting yield while cutting down production costs

Improving solubility and bioavailability

Fostering new combination therapy advancements

Enhancing shelf stability, especially in tropical climates


With our innovation-driven approach, we proudly position ourselves as a forward-thinking supplier of API Bulk Drugs, dedicated to providing next-generation pharmaceutical solutions.


Certifications and Quality Accreditations


We take pride in our facilities being accredited by:


WHO-GMP

EU-GMP

ISO 9001:2015

Indian FDA and various other regulatory bodies


These certifications not only bolster our credibility but also affirm our ability to deliver high-quality lumefantrine IP USP to both regulated and semi-regulated markets.


Client Satisfaction and Global Reach


We're proud to say that our growing client base stretches across over 40 countries, including leading pharmaceutical companies, contract manufacturers, and public health organizations. Our focus on putting customers first, combined with our top-notch API Bulk Drugs, builds trust and satisfaction in every partnership we forge.


Conclusion: Partner with a Trusted Leader in Lumefantrine Supply


As a dedicated ally in global health, Prism Industries Pvt. Ltd. stands out for its exceptional quality and reliability in producing lumefantrine IP USP. Acknowledged as one of India's premier API manufacturers, we are devoted to supporting WHO-compliant therapies and improving access to life-saving malaria treatments.

With decades of experience in API Bulk Drugs, sustainable manufacturing practices, and a commitment to customer service, we are your reliable partner for long-term success in antimalarial API supply.


Choose Prism Industries Pvt. Ltd.—where excellence in lumefantrine manufacturing aligns with the needs of global healthcare.


Comments

Popular posts from this blog

How Hyoscine Butyl Bromide Works: Mechanism and Applications

Nicotine Bitartrate Dihydrate & NRT Products by Prism Industries Pvt. Ltd.

Nicotine USP: Key Role in Smoking Cessation Products and Nicotine Gum Benefits